- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00224159
Does Statin Initiation Undermine Dietary Behavior?
February 18, 2011 updated by: Weill Medical College of Cornell University
The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study explores the impact of initiating statin therapy on subsequent dietary as well as other lifestyle beliefs, attitudes and behaviors.
Specific aims:
- To test whether the initiation of statin therapy increases dietary saturated fat intake among statin naive patients.
- To determine what role attitudes, beliefs, expectations, motivation, intention and self-efficacy regarding drug or diet therapy may play in observed changes in dietary behavior after starting statin therapy.
Study Type
Observational
Enrollment
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- The New York Presbyterian Hospital-Weill Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.
Description
Inclusion Criteria:
All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.
Exclusion Criteria:
Will include a history of any of the following:
- Prior CVD (myocardial infarction, angina, angioplasty, stroke, CABG. or arterial bypass surgery)
- Diabetes patients
- Psychiatric patients
- AIDS patients
- Substance abuse patients
- Prior cholesterol lowering medication use
- Inability to complete the interviews
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
How drug or dietary therapy may play a role in dietary behavior.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Sundar Natarajan, MD, MSc, Weill Medical College of Cornell University
- Principal Investigator: Devin Mann, MD, Weill Medical College of Cornell University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2005
Study Completion
June 1, 2006
Study Registration Dates
First Submitted
September 20, 2005
First Submitted That Met QC Criteria
September 20, 2005
First Posted (Estimate)
September 22, 2005
Study Record Updates
Last Update Posted (Estimate)
February 21, 2011
Last Update Submitted That Met QC Criteria
February 18, 2011
Last Verified
February 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- 00710
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug and Dietary behavior
-
Dynamic Health ResourcesUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingHealthy SubjectUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedBorderline Personality Disorder | Opiate AddictionUnited States
-
Sansum Diabetes Research InstituteRecruitingDiabetes Mellitus, Type 2 | Diabetes Mel Gestational - in PregnancyUnited States
-
University Hospital Inselspital, BerneTakedaCompleted
-
Florida State UniversityCompleted
-
Cedars-Sinai Medical CenterNational Alliance for Research on Schizophrenia and DepressionCompleted
-
The University of Texas Health Science Center,...National Institute on Drug Abuse (NIDA)Completed
-
Mackay Memorial HospitalMinistry of Science and Technology, TaiwanCompletedBorderline Personality DisorderTaiwan
-
University of Electronic Science and Technology...Recruiting